Table 1 Demographic characteristics of... | American Society of Hematology

Table 1

Demographic characteristics of patients

Variable	Control, n = 60	SLE, n = 135
Females, %	55	95
Age, mean (SEM)	38 (3)	41 (1.3)
Disease activity SLEDAI, mean	—	4.8 (5.2)
(SEM)
SLEDAI less than 2, %	—	39
SLEDAI 2 or greater, %	—	61
Medications, %	—
Antimalarials	—	66
Azathioprine	—	4
Mycophenolate	—	11
Cyclophosphamide	—	3
Methotrexate	—	7
Prednisone less than 0.5 mg/kg/d	—	58
Prednisone 0.5–1 mg/kg/d	—	6
Prednisone greater than 1 mg/kg/d	—	1
No immunosuppression	—	12
Past or current lupus nephritis, %	—	25
Positive antiphospholipid Ab, β2-glycoprotein antibody, and/or lupus anticoagulant, %	—	15

Variable	Control, n = 60	SLE, n = 135
Females, %	55	95
Age, mean (SEM)	38 (3)	41 (1.3)
Disease activity SLEDAI, mean	—	4.8 (5.2)
(SEM)
SLEDAI less than 2, %	—	39
SLEDAI 2 or greater, %	—	61
Medications, %	—
Antimalarials	—	66
Azathioprine	—	4
Mycophenolate	—	11
Cyclophosphamide	—	3
Methotrexate	—	7
Prednisone less than 0.5 mg/kg/d	—	58
Prednisone 0.5–1 mg/kg/d	—	6
Prednisone greater than 1 mg/kg/d	—	1
No immunosuppression	—	12
Past or current lupus nephritis, %	—	25
Positive antiphospholipid Ab, β2-glycoprotein antibody, and/or lupus anticoagulant, %	—	15

— indicates not applicable.